Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paulina Glajzner"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Drug repurposing (repositioning) is a dynamically-developing area in the search for effective therapy of infectious diseases. Repositioning existing drugs with a well-known pharmacological and toxicological profile is an attractive method for quickly
Externí odkaz:
https://doaj.org/article/5d89dca0abb546ceb4f4cc6389464701
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Multidrug-resistant coagulase-negative staphylococci represent a real therapeutic challenge. The aim of the study was to emphasize the importance of heteroresistance to vancomycin presence in methicillin-resistant strains of S. epidermidis.
Externí odkaz:
https://doaj.org/article/555497cc54434a22bc05e7d252f71c75
Publikováno v:
Folia Microbiologica. 68:231-243
Crossing of interspecies barriers by microorganisms is observed. In recent years, Staphylococcus pseudintermedius—a species formerly thought to be animal—has also been isolated from human clinical materials. Many virulence factors are responsible
Publikováno v:
Current Microbiology. 80
Recently, the phenomenon of infection of humans as hosts by animal pathogens has been increasing. Streptococcus is an example of a genus in which bacteria overcome the species barrier. Therefore, monitoring infections caused by new species of human p
Publikováno v:
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
Besides being an essential part of the skin microbiome, coagulase-negative staphylococci are the etiological factors of serious infections. The aim of the study was to evaluate the heteroresistance to vancomycin and the potential antimicrobial effica
Autor:
Paulina Glajzner
Publikováno v:
Farmacja Polska. 75:148-156
Publikováno v:
Journal of Medical Microbiology. 70
Bacteria of the genusStreptococcus, earlier considered typically animal, currently have also been causing infections in humans. It is necessary to make clinicians aware of the emergence of new species that may cause the development of human diseases.